OBJECTIVE: Amplitude-integrated electroencephalography (aEEG) is a useful bedside tool in predicting the neurodevelopmental outcome after neonatal encephalopathy; however, the prognostic accuracy may be altered by rescue hypothermic neuroprotection. The objective of this study is to examine the prognostic accuracy of aEEG for predicting long-term neurodevelopmental outcomes in term newborn infants undergoing therapeutic hypothermia for neonatal encephalopathy.
INTRODUCTION
Amplitude-integrated electroencephalography (aEEG) is a widely used bedside tool to identify potential candidates for therapeutic hypothermia after a perinatal asphyxia insult, for identifying seizures and for guiding limitation of life-sustaining therapy in severely encephalopathic infants. The aEEG acquired within the first 6 h of age was considered one of the best predictors of neurological outcome at 18 months in non-cooled neonatal encephalopathy (NE) infants. 1 However, since the widespread use of cooling therapy, the predictive value of early aEEG has changed and NE infants have been shown to have a normal neurological outcome if the aEEG background voltage activity recovers by 48 h. [2] [3] [4] The aim of this study was to review systematically the published literature and perform a meta-analysis of the prognostic accuracy of aEEG for predicting long-term neurodevelopmental outcomes in near-term and term newborn infants with NE undergoing rescue hypothermic neuroprotection.
METHODS
We followed the guidelines of the Cochrane Diagnostic Test Accuracy Working Group for undertaking and reporting the meta-analysis. We included all the studies that compared the prognostic accuracy of aEEG during the first few days after birth with neurodevelopmental outcome at 1 year or more, after therapeutic hypothermia (selective head cooling or whole body cooling) for NE in babies 436 weeks. If both hypothermic and normothermic infants were included in a study, we extracted the aEEG data of the hypothermic infants, separately. We excluded the study if such separate analysis was not possible or if the aEEG background was not described as in pattern or voltage classification. 1, 5 Index test: aEEG We used the following definition for each tracing: continuous normal voltage is a continuous background activity with voltage of 10 to 25 mV; discontinuous normal voltage is a discontinuous trace with voltage 45 mV; BS (burst suppression) is discontinuous trace with periods of low cortical activity ( o5 mV) with bursts of higher amplitude; continuous low voltage is continuous background pattern of voltage, around or o 5 mV; flat tracing is mainly isoelectric tracing of o 5 mV; and epileptiform activity is a single or repetitive event with sustained cortical activity. We considered continuous normal voltage pattern as normal and discontinuous normal voltage, burst suppression, flat trace and persistently low voltage as abnormal. 6 If the background was described by voltage method, 5 we considered normal trace as normal, moderately abnormal, severely abnormal trace and burst suppression as abnormal. We collected the aEEG data at 6, 24, 48 and 72 h after birth, whenever available.
Reference test
All included babies had a detailed neurological examination and neurodevelopmental score using a standard measurement tool (Griffiths Mental Developmental Scales, Bayley Scales of Infant Development, Alberta Infant Motor Scale 7 ) at 1 year or more. The presence and type of cerebral palsy was determined according to Hagberg et al. 8 and severity classified using the Gross Motor Function Classification System. 9 We considered death or moderate, or severe neurodisability as adverse outcomes. Moderate-severe neurodisability was defined in the included studies as any of the following: Gross Motor Function Classification System level 3 to 5 (corresponding to moderate/severe cerebral palsy), hearing impairment that required hearing aids, blindness, mental development index o 70 (refs 2,4,10,11) or Griffiths Mental Developmental Scales DQ o85. 12 Hallberg et al. 3 considered severe disability in case of neurological examinations 13 with overt signs of spasticity and an Alberta infant Motor Scale 7 score below the fifth percentile. We also searched the Cochrane CENTRAL library and conference abstracts. We included only human studies.
Statistical analysis and data synthesis. Three investigators (MC, BC and PM) independently extracted the individual patient data from each of the studies into a predefined database. The fourth reviewer (ST) resolved any inter-reviewer differences. We used Revman (Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.) for metaanalysis. We then pooled the individual patient data from all studies to create 2 × 2 tables and calculated the prognostic indices with 95% confidence intervals (CIs) using exact statistics. 14 For direct comparison of diagnostic utility at various time points, we used diagnostic odds ratios 15 and area under the curve. Inter-study heterogeneity was investigated using χ 2 -tests and I 2 index. To minimize clinical heterogeneity, we excluded all preterm infants (o36 weeks gestation), babies who did not receive hypothermic neuroprotection and infants who did not have neurodevelopmental assessment at the age of 12 months or after. We examined the quality of all the included studies using Quadas 2 method; 16 this included patient selection, index test, reference standard, flow and timing and applicability concerns for each study.
RESULTS
We reviewed 70 abstracts; 17 met the initial inclusion criteria and were selected for review with full text. Five studies were excluded, because they did not report long-term outcome. [17] [18] [19] [20] [21] One study was excluded because of duplication, 22 one study was excluded as we were unable to extract data 23 and another one was excluded because of using only acquisition of sleep-wake cycle rather than full background of aEEG as an index test. 24 Thus, a total of nine studies were included in the final meta-analysis. [2] [3] [4] [10] [11] [12] [25] [26] [27] ( Figure 1 ).
Individual patient data were available from all nine included studies ( Supplementary Information, Supplementary Table 1) ; thus, we compared the aEEG data from 520 cooled encephalopathic babies who had neurodevelopmental outcome assessments aged 412 months. The pooled results of the meta-analysis, indicating the accuracy of severe aEEG tracings acquired at different hours of age, to predict moderate/severe disability or death, are summarized in Figures 2, 3, 4 .
Accuracy of 6 h aEEG (before the initiation of therapeutic hypothermia) Although aEEG had a good sensitivity 96% (CI 95%, 91 to 98) at 6 h of age, the specificity (39%; CI 95%, 32 to 46) was poor ( Figure 2 ). The diagnostic odds ratio (8.2; CI 95%, 3.8 to 17.7) for predicting adverse outcomes was modest (Figure 4) . A severely abnormal aEEG trace at 6 h of age was associated with an adverse outcome in 111 (94%) out of 117 infants. A good outcome was seen in 216 cooled babies, out of which only 84 (39%) had a normal background at 6 h of age.
The predictive value of aEEG between 24 to 72 h (that is, during therapeutic hypothermia) The predictive values of an abnormal trace during hypothermia at 24 (n = 175 babies), 48 (n = 130 babies) and 72 (n = 125 babies) hours of age are shown in Figure 3 . The diagnostic odds ratios were 39.6 (95% CI 13.1, 119), 66.9 (95% CI 19.7, 227.2) and 47.99 (95% CI 11.4, 201.7) at 24, 48 and 72 h, respectively (Figure 4) . The positive predictive value of a persistently abnormal aEEG increased from 66% at 24 h, to 85% at 48 h and 89% at 72 h, for predicting adverse outcomes (Supplementary Information). We checked the accuracy of this predictive ability; the accuracy was best at 48 h (area under the curve 0.90 SE0.06) (Supplementary Information). Only 3 out of 27(11%) babies had a normal outcome despite a persistently abnormal aEEG at 72 h.
Heterogeneity and methodological quality of included studies Overall, the risks of bias in the index test, and flow and timing were low (Table 1 and Figure 5 ). In patient selection, the study by Hallberg et al. 3 had a high risk of bias, as they did not use standard patient selection criteria. They also used a non-standard method Predictive value of amplitude-integrated EEG M Chandrasekaran et al of outcome assessment and measured only motor outcome. The studies by Ancora et al. 26 and Gucuyener et al. 10 were limited by small sample size. In the study by Gucuyener et al., 10 some infants had their outcome assessed before 12 months of age. However, majority of the included studies had large sample size.
Five studies 3,4,10,11,25 used total body cooling and three studies 12, 26, 27 used selective head cooling with mild systemic hypothermia. One study used both whole body cooling and selective head cooling. 2 Regarding the aEEG monitors, five studies used single channel Olympic monitors (Olympic CFM 6000 Monitor or CFM 5330; Olympic Medical, Seattle, WA, USA), one study used both Olympic and Brainz (BRM; Natus, Seattle, WA) monitors, the others used multi-channel Nervus monitor (Viasys, Nicole Biomedical, Madison, WI, USA), single channel Lectromed (Lectromed, Letchworth, UK) and multi-channel Moberg monitor (Moberg Research, Ambler, PA, USA). Despite the difference in devices, the aEEG background was reported in structured manner in all the included studies, using pattern classification 1 in seven studies and voltage classification 5 in two studies. This standard classification minimized the bias. Overall, none of the included studies had high risk for bias (Table 1) .
DISCUSSION
In this review, we systematically evaluated the predictive value of an abnormal trace, acquired at 6, 24, 48 and 72 h of age, among infants who had therapeutic hypothermia for moderate or severe NE. The data highlight two clinically important observations as follows: (a) a persistently severely abnormal aEEG background at 48 h of age or beyond predicts the adverse outcome (positive predictive value 85% and diagnostic odds ratio 67 at 48 h) and (b) at 6 h of age, the aEEG background in hypothermia-treated infants has a good sensitivity 96% (95% CI 89 to 97%) but unfortunately, the specificity 39% (95% CI 32 to 45%) is quite poor. A persistently abnormal aEEG between 6 and 24 h of age has been associated with adverse outcomes in the pre-cooling era. 1, 2, 5 Our data suggest that therapeutic hypothermia has shifted this time window and adverse outcome were seen only if a severely abnormal aEEG was persistent for at least 48 h. This shift in the prognostic accuracy could be explained, at least partly by the neuroprotective effects of therapeutic hypothermia. Clinicians often use persistent aEEG background abnormalities to re-direct life-sustaining therapy and to counselling parents about long-term adverse neurological outcome. This alteration in the prognostic accuracy of aEEG with therapeutic hypothermia needs to be considered in such decision-making.
Abnormal 6 h aEEG was a mandatory inclusion criterion for some cooling trials, 23, 27, 28 although the incremental benefits of aEEG over a structured neurological examination remains unclear. Our data suggest that the positive predictive value of an abnormal 6 h aEEG is poor in cooled babies and is lower than previous studies in the precooling era. 29, 30 Again, this observation could be explained by the beneficial effect of therapeutic hypothermia. This finding might have important implications if aEEG is used as an inclusion criterion in future clinical trials of adjunct cooling therapies. Our findings are in agreement with the study of Sarkar et al. 19 who showed that an abnormal 6 h aEEG does not always correlate with early death or abnormal magnetic resonance imaging brain scan. Although, our study underlines that 6 h aEEG has a good sensitivity and negative predictive value, there is still a 7% of babies with a poor outcome despite a normal aEEG. Besides, caution needs to be exercised in withholding cooling therapy based on a normal 6 h aEEG alone.
We analyzed the studies, which reported the aEEG background based on voltage classification, separately. The accuracy of an abnormal aEEG at 6 h to predict adverse outcome (web extra Figure 1 ) did not differ from the one earlier mentioned, based on pattern classification. The pooled sensitivity was 87% (95% CI 80 to 92%) and specificity was 36% (95% CI 29 to 44%). However, the heterogeneity among the studies was very high (I 2 480%). This was difficult to explain; nevertheless, it could be due to the fact that aEEG background was used as an inclusion criterion for some of the included studies.
Three previous systematic reviews have examined the prognostic accuracy of aEEG in neonatal encephalopathy; however, our study is the only meta-analysis focussing specifically on cooled encephalopathic infants at multiple time points. Spitzmiller et al. 31 reported high prognostic accuracy (sensitivity (91%) and specificity (88%)) of aEEG in neonatal encephalopathy, but their work included only normothermic babies. van Laerhoven et al. 32 also reported high prognostic accuracy of aEEG (sensitivity and specificity 490%), but again this review focussed on normothermic infants. Finally, Awal et al. 33 reported high prognostic accuracy of aEEG in neonatal encephalopathy, but they included both cooled and normothermic infants, and included studies with short-term outcome (3 months). Furthermore, the authors combined EEG and aEEG data, and did not specifically examine the prognostic accuracy of aEEG.
There are some limitations to our review. Although, we analysed studies based on the description of the aEEG background (pattern recognition or voltage) separately, we projected the data from the studies by pattern recognition only, as there was significant heterogeneity among the studies based on voltage classification when we combined the data (I 2 480%). Perhaps, some may argue that pattern recognition is more subjective, is considered more sensitive than voltage measurements in predicting outcome. 29, 34 Secondly, the TOBY 4 and Coolcap studies 27 , which were included in the analysis, required the presence of an abnormal aEEG for eligibility. However, this may not have influenced the positive predictive value. Finally, we have not examined other facets of an aEEG such as the sleep-wake cycles, time to recovery, seizures and use of sedatives and its effects on outcome. The data available on such factors were limited. Moreover, the quality of the included studies may have been affected by the other factors such as varied cooling equipment, different method of cooling between the studies, small sample size in couple of studies and different centres 'policy about redirecting care. However, the quadas assessment did not reveal any major risk of bias in the included studies. Besides, the mortality rate in the different studies is in keeping with that reported in literature (up to 30%) 35 , which makes unlikely that withdrawal of intensive support might have affected our results.
CONCLUSION
Therapeutic hypothermia alters the predictive value of an aEEG background at all time points during induction and maintenance phase of hypothermia. The predictive ability of an aEEG background at 6 h of age during induction of TH is sub-optimal and there may be little benefit in using an abnormal aEEG as an inclusion criteria in future clinical trials of adjunct neuroprotective therapies. Persistently abnormal trace at 48 h of age or more was associated with adverse long-term outcome and may be useful as an adjunct bedside investigation for clinical decision making about limitation of life-sustaining therapy.
